Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNY3 pseudogene 5 (RNY3P5) is a **pseudogene** in the human genome originating from the RNY3 gene, part of the Y RNA family. While functional Y RNAs such as RNY3 (also called hY3) are involved in RNA processing, DNA replication, and interactions with proteins like Ro60 in ribonucleoprotein complexes, *pseudogenes* like RNY3P5 are generally regarded as non-functional remnants of gene duplication or retrotransposition events and typically do not encode functional RNA or protein products[1][2][3].\nThousands of Y RNA pseudogenes exist in the human genome, many with >90% sequence similarity to the four main human Y RNAs (RNY1, RNY3, RNY4, RNY5), but few have any demonstrated biological activity[1][2].\nThere is currently no evidence that RNY3P5 is a functional gene product, therapeutic target, or biomarker. Its relevance is primarily genomic annotation.\nThe parent functional gene, RNY3, is associated with RNA quality control, immune functions, and DNA replication, but these roles are not attributed to RNY3P5 or other pseudogenes[1][2][3][5].\n\n**Summary**:\n"RNY3 pseudogene 5" is **not a canonical molecular target** but an annotated non-functional pseudogene derived from RNY3. No drugs, disease roles, or therapeutic significance have been attributed to this entity to date. If you meant the functional gene RNY3 or its RNA (hY3), please clarify, as these have established biological roles and limited disease relevance[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNY3 pseudogene 5 (RNY3P5).